Secretory meningioma: clinical, histologic, and immunohistochemical findings in 31 cases
- PMID: 9149029
- DOI: 10.1002/(sici)1097-0142(19970515)79:10<2003::aid-cncr23>3.0.co;2-x
Secretory meningioma: clinical, histologic, and immunohistochemical findings in 31 cases
Abstract
Background: Secretory meningioma is a rare histologic variant characterized by a unique epithelial differentiation of meningothelial cells resulting in the production of hyaline inclusions. Most previous reports have presented single case observations. The authors selected 31 cases for a clinicopathologic study to characterize this type of tumor further.
Methods: Clinical data were compiled and the extent of peritumoral edema was assessed from preoperative computed tomography or magnetic resonance imaging scans. Preparations of surgical specimens of all tumors were studied after both conventional histologic and immunohistochemical preparations were made. Immunostaining was performed by either the avidin-biotin complex method or the alkaline phosphatase-antialkaline phosphatase method using 22 primary antibodies.
Results: In the tumor collection used in this study, secretory meningiomas represented 3% of meningiomas. The female-to-male ratio was 9:1. Most tumors were located at the sphenoid ridge or at the frontal convexity, and recurrences were not observed. Eighty-four percent of tumors presented with slight to marked peritumoral edema. The MIB-1 staining index showed a mean of 3.8%. Inclusions and surrounding cells consistently expressed epithelial membrane antigen, cytokeratins, carcinoembryonic antigen, and carbohydrate antigen 19-9. In decreasing frequency, they also contained alpha1-antitrypsin, immunoglobulin (Ig)A, alpha1-antichymotrypsin, IgM, and IgG. Cells positive for vimentin and S-100 did not contain inclusions. All tumors were positive for progesterone receptors. Macrophages were stained with antibodies to factor XIIIa, human leukocyte antigen-DR, and alpha1-antitrypsin. In 64% of cases, tumor vessels lacked expression of glucose transporter protein 1.
Conclusions: The classification of secretory meningioma as a distinct variant has been justified on clinical, histologic, and immunohistochemical grounds. The unique epithelial features call attention to the broad spectrum of differentiation properties found in meningiomas.
Similar articles
-
Secretory meningiomas.J Neurooncol. 2003 May;62(3):233-41. doi: 10.1023/a:1023319407645. J Neurooncol. 2003. PMID: 12777074 Review.
-
Secretory meningiomas: clinical and immunohistochemical observations.Neurosurgery. 2001 Feb;48(2):297-301; discussion 301-2. doi: 10.1097/00006123-200102000-00008. Neurosurgery. 2001. PMID: 11220371
-
Intracytoplasmic lumina in meningioma: an ultrastructural and immunohistological study.Neurosurgery. 1988 Aug;23(2):180-4. doi: 10.1227/00006123-198808000-00009. Neurosurgery. 1988. PMID: 2460798
-
Secretory meningioma. A distinct subtype of meningioma.Am J Surg Pathol. 1986 Feb;10(2):102-11. doi: 10.1097/00000478-198602000-00003. Am J Surg Pathol. 1986. PMID: 2420220
-
Secretory meningioma with elevated serum carcinoembryonic antigen level.Surg Neurol. 1992 May;37(5):415-8. doi: 10.1016/0090-3019(92)90015-f. Surg Neurol. 1992. PMID: 1631772 Review.
Cited by
-
Occurrence of Fibrotic Tumor Vessels in Grade I Meningiomas Is Strongly Associated with Vessel Density, Expression of VEGF, PlGF, IGFBP-3 and Tumor Recurrence.Cancers (Basel). 2020 Oct 21;12(10):3075. doi: 10.3390/cancers12103075. Cancers (Basel). 2020. PMID: 33096816 Free PMC article.
-
Secretory meningiomas.J Neurooncol. 2003 May;62(3):233-41. doi: 10.1023/a:1023319407645. J Neurooncol. 2003. PMID: 12777074 Review.
-
The Emerging Role of TRAF7 in Tumor Development.J Cell Physiol. 2017 Jun;232(6):1233-1238. doi: 10.1002/jcp.25676. Epub 2017 Jan 6. J Cell Physiol. 2017. PMID: 27808423 Free PMC article. Review.
-
Secretory Meningioma Mimicking Malignancy.Med J Armed Forces India. 2008 Jan;64(1):82-3. doi: 10.1016/S0377-1237(08)80162-1. Epub 2011 Jul 21. Med J Armed Forces India. 2008. PMID: 27408092 Free PMC article. No abstract available.
-
Reactive hyperplasia of vascular pericytes in meningioma: immunohistochemical and ultrastructural studies of two cases.Int J Clin Exp Pathol. 2022 Aug 15;15(8):316-322. eCollection 2022. Int J Clin Exp Pathol. 2022. PMID: 36106072 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous